Comparison of erythropoietin resistance in hemodialysis patients using calcitriol, cinacalcet, or paricalcitol

Journal of Clinical Pharmacology

Volumn 55, Issue 11, 2015, Pages 1280-1285

  Afsar, Baris ^a   Agca, Erhan ^a   Turk, Suleyman ^b  

^a Konya Numune State Hospital   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

anemia; cinacalcet; erythropoietin; hemodialysis; paricalcitol; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM ACETATE; CALCIUM CARBONATE; CINACALCET; ERYTHROPOIETIN; IRON; PARICALCITOL; PHOSPHATE BINDING AGENT; SEVELAMER; ANTIANEMIC AGENT; ERGOCALCIFEROL; HEMOGLOBIN; UREA;

ADULT; ANEMIA; ARTICLE; BIOCHEMICAL ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; IRON DEFICIENCY; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; PHYSICAL EXAMINATION; AGED; BLOOD; COMPARATIVE STUDY; DRUG RESISTANCE; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CALCITRIOL; CINACALCET HYDROCHLORIDE; DRUG RESISTANCE; ERGOCALCIFEROLS; ERYTHROPOIETIN; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; UREA;

EID: 84942886634     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/jcph.556     Document Type: Article

References (25)

1. Afsar B,. The relationship between depressive symptoms and erythropoietin resistance in stable hemodialysis patients with adequate iron stores. Int J Artif Organs. 2013; 36: 314-319.
2. Afsar B, Saglam M, Yuceturk C, Agca E., The relationship between red celldistribution width with erythropoietin resistance in iron replete hemodialysis patients. Eur J Intern Med. 2013; 24: e25-e9.
3. Smrzova J, Balla J, Bárány P., Inflammation and resistance to erythropoiesis-stimulating agents-what do we know and what needs to be clarified? Nephrol Dial Transplant. 2005; 20 (Suppl 8): viii2-viii7.
4. Johnson DW, Pollock CA, Macdougall IC., Erythropoiesis-stimulating agent hyporesponsiveness. Nephrology (Carlton). 2007; 12: 321-330.
5. Lõpez-Gõmez JM, Portolés JM, Aljama P., Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int Suppl. 2008; S75-S81.
6. Lõpez-Gõmez JM, Pérez-Flores I, Jofré R, et al., Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance. J Am Soc Nephrol. 2004; 15: 2494-2501.
7. Icardi A, Paoletti E, De Nicola L, Mazzaferro S, Russo R, Cozzolino M., Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation. Nephrol Dial Transplant. 2013; 28: 1672-1679.
8. Patel NM, Gutiérrez OM, Andress DL, Coyne DW, Levin A, Wolf M., Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int. 2010; 77: 715-720.
9. Perlstein TS, Pande R, Berliner N, Vanasse GJ., Prevalence of 25-hydroxyvitamin. D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation. Blood. 2011; 117: 2800-2806.
10. Kiss Z, Ambrus C, Almasi C, et al., Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis. Nephron Clin Pract. 2011; 117: c373-c378.
11. Battistella M, Richardson RM, Bargman JM, Chan CT., Improved parathyroid hormone control by cinecalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal disease. Clin Nephrol. 2011; 76: 99-103.
12. Fusaro M, D'Angelo A, Naso A, et al., Treatment with calcimimetic (cinacalcet) alters epoetin dosage requirements in dialysis patients: preliminary report. Ren Fail. 2011; 33: 732-735.
13. Capuano A, Serio V, Pota A, Memoli B, Andreucci VE., Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients. J Nephrol. 2009; 22: 59-68.
14. Macdougall IC., How to optimise anaemia therapy in peritoneal dialysis patients. Contrib Nephrol. 2006; 150: 202-213.
15. Nurko S., Anemia in chronic kidney disease: causes, diagnosis, treatment. Cleve Clin J Med. 2006; 73: 289-297.
16. Kendrick J, Targher G, Smits G, Chonchol M., 25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease. Am J Nephrol. 2009; 30: 64-72.
17. Goicoechea M, Vazquez MI, Ruiz MA, Gomez-Campdera F, Perez-García R, Valderrábano F., Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron. 1998; 78: 23-27.
18. Kumar VA, Kujubu DA, Sim JJ, Rasgon SA, Yang PS., Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. J Nephrol. 2011; 24: 98-105.
19. Viana H, Vila Lobos A, Resina C, et al., Treatment of secondary hyperparathyroidism with cinacalcet is associated with an increase in hemoglobin levels. Port J Nephrol Hypert. 2007; 21: 225-229.
20. Tan X, Wen X, Liu Y., Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF- kappa B signaling. J Am Soc Nephrol. 2008; 19: 1741-1752.
21. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I, Galaktidou G., Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-alpha and IL-8 production by human peripheral blood mononuclear cells. Int Urol Nephrol. 2010; 42: 181-185.
22. Guerrero F, Montes de Oca A, Aguilera-Tejero E, Zafra R, Rodríguez M, Lõpez I,. The effect of vitamin D derivatives on vascular calcification associated with inflammation. Nephrol Dial Transplant. 2012; 27: 2206-2212.
23. Kimata N, Akiba T, Pisoni RL, et al., Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2005; 20: 927-935
24. Misiti J, Spivak JL., Erythropoiesis in vitro: role of calcium. J Clin Invest. 1979; 64: 1573-1579.
25. Chu X, Tong Q, Cheung JY, et al., Interaction of TRPC2 and TRPC6 in erythropoietin modulation of calcium influx. J Biol Chem. 2004; 279: 10514-10522.